Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-04-17 | Vericel Corp | Colangelo Dominick
(President and CEO) |
S | Common Stock | D | 35000 | $44.59 - $46.47 | $1,593,550 |
| 2024-04-17 | Vericel Corp | Colangelo Dominick
(President and CEO) |
M | Common Stock | A | 35000 | $3.02 - $3.02 | $105,700 |
| 2024-04-09 | Vericel Corp | Rubino Alan L
(Director) |
M | Common Stock | A | 3000 | $4.12 - $4.12 | $12,360 |
| 2024-03-27 | Vericel Corp | ZERBE ROBERT L MD
(Director) |
S | Common Stock | D | 3278 | $51.57 - $51.57 | $169,046 |
| 2024-03-27 | Vericel Corp | ZERBE ROBERT L MD
(Director) |
M | Common Stock | A | 3278 | $3.74 - $3.74 | $12,259 |
| 2024-03-13 | Vericel Corp | Colangelo Dominick
(President and CEO) |
S | Common Stock | D | 35000 | $44.02 - $44.67 | $1,552,075 |
| 2024-03-13 | Vericel Corp | Colangelo Dominick
(President and CEO) |
M | Common Stock | A | 35000 | $3.02 - $3.02 | $105,700 |
| 2024-03-11 | Vericel Corp | Halpin Michael
(Chief Operating Officer) |
S | Common Stock | D | 7874 | $44.71 - $44.71 | $352,046 |
| 2024-03-07 | Vericel Corp | SIEGAL JONATHAN
(Principal Accounting Officer) |
S | Common Stock | D | 1634 | $45.00 - $45.00 | $73,530 |
| 2024-03-08 | Vericel Corp | Flynn Sean C.
(SVP, General Counsel) |
S | Common Stock | D | 8115 | $45.33 - $45.33 | $367,852 |
| 2024-02-20 | Vericel Corp | ZERBE ROBERT L MD
(Director) |
S | Common Stock | D | 722 | $50.01 - $50.01 | $36,107 |
| 2024-02-20 | Vericel Corp | ZERBE ROBERT L MD
(Director) |
M | Common Stock | A | 722 | $3.74 - $3.74 | $2,700 |
| 2024-02-20 | Vericel Corp | Halpin Michael
(Chief Operating Officer) |
M | Common Stock | A | 11887 | $0.00 - $0.00 | $0 |
| 2024-02-20 | Vericel Corp | Halpin Michael
(Chief Operating Officer) |
F | Common Stock | D | 5731 | $49.50 - $49.50 | $283,684 |
| 2024-02-20 | Vericel Corp | Flynn Sean C.
(SVP, General Counsel) |
M | Common Stock | A | 7075 | $0.00 - $0.00 | $0 |
| 2024-02-20 | Vericel Corp | Flynn Sean C.
(SVP, General Counsel) |
F | Common Stock | D | 3250 | $49.50 - $49.50 | $160,874 |
| 2024-02-20 | Vericel Corp | Colangelo Dominick
(President and CEO) |
M | Common Stock | A | 38887 | $0.00 - $0.00 | $0 |
| 2024-02-20 | Vericel Corp | Colangelo Dominick
(President and CEO) |
F | Common Stock | D | 18025 | $49.50 - $49.50 | $892,236 |
| 2024-02-20 | Vericel Corp | Mara Joseph Antho...
(Chief Financial Officer) |
M | Common Stock | A | 7380 | $0.00 - $0.00 | $0 |
| 2024-02-20 | Vericel Corp | Mara Joseph Antho...
(Chief Financial Officer) |
F | Common Stock | D | 2268 | $49.50 - $49.50 | $112,265 |
| 2024-02-20 | Vericel Corp | SIEGAL JONATHAN
(Principal Accounting Officer) |
M | Common Stock | A | 2920 | $0.00 - $0.00 | $0 |
| 2024-02-20 | Vericel Corp | SIEGAL JONATHAN
(Principal Accounting Officer) |
F | Common Stock | D | 1286 | $49.50 - $49.50 | $63,656 |
| 2024-02-20 | Vericel Corp | Hopper Jonathan Mark
(Chief Medical Officer) |
M | Common Stock | A | 7075 | $0.00 - $0.00 | $0 |
| 2024-02-20 | Vericel Corp | Hopper Jonathan Mark
(Chief Medical Officer) |
F | Common Stock | D | 3106 | $49.50 - $49.50 | $153,746 |
| 2024-02-14 | Vericel Corp | Colangelo Dominick
(President and CEO) |
S | Common Stock | D | 35000 | $46.99 - $48.85 | $1,677,200 |
| 2024-02-14 | Vericel Corp | Colangelo Dominick
(President and CEO) |
M | Common Stock | A | 35000 | $3.02 - $3.02 | $105,700 |
| 2023-03-31 | Vericel Corp | Mara Joseph Antho...
(Chief Financial Officer) |
A | Common Stock | A | 370 | $21.36 - $28.49 | $9,400 |
| 2023-12-31 | Vericel Corp | SIEGAL JONATHAN
(Principal Accounting Officer) |
A | Common Stock | A | 95 | $28.21 - $28.21 | $2,679 |
| 2024-01-29 | Vericel Corp | ZERBE ROBERT L MD
(Director) |
S | Common Stock | D | 2300 | $44.22 - $44.22 | $101,706 |
| 2024-01-22 | Vericel Corp | ZERBE ROBERT L MD
(Director) |
S | Common Stock | D | 8000 | $41.39 - $42.06 | $334,774 |
| 2024-01-22 | Vericel Corp | ZERBE ROBERT L MD
(Director) |
M | Common Stock | A | 3000 | $4.12 - $4.12 | $12,360 |
| 2024-01-17 | Vericel Corp | Colangelo Dominick
(President and CEO) |
S | Common Stock | D | 33452 | $37.97 - $38.58 | $1,280,375 |
| 2024-01-17 | Vericel Corp | Colangelo Dominick
(President and CEO) |
M | Common Stock | A | 33452 | $3.02 - $3.02 | $101,024 |
| 2024-01-12 | Vericel Corp | ZERBE ROBERT L MD
(Director) |
S | Common Stock | D | 2200 | $38.09 - $38.09 | $83,798 |
| 2023-12-14 | Vericel Corp | Wotton Paul K
(Director) |
S | Common Stock | D | 5000 | $37.31 - $37.31 | $186,550 |
| 2023-12-13 | Vericel Corp | Colangelo Dominick
(President and CEO) |
M | Common Stock | A | 24000 | $3.57 - $3.57 | $85,680 |
| 2023-12-13 | Vericel Corp | Colangelo Dominick
(President and CEO) |
G | Common Stock | D | 6757 | $0.00 - $0.00 | $0 |
| 2023-11-30 | Vericel Corp | Halpin Michael
(Chief Operating Officer) |
S | Common Stock | D | 17447 | $35.41 - $35.41 | $617,798 |
| 2023-11-30 | Vericel Corp | Halpin Michael
(Chief Operating Officer) |
M | Common Stock | A | 17447 | $7.20 - $7.20 | $125,618 |
| 2023-11-20 | Vericel Corp | Hopper Jonathan Mark
(Chief Medical Officer) |
S | Common Stock | D | 5000 | $36.40 - $36.40 | $182,000 |
| 2023-11-20 | Vericel Corp | Hopper Jonathan Mark
(Chief Medical Officer) |
M | Common Stock | A | 5000 | $10.95 - $10.95 | $54,750 |
| 2023-11-15 | Vericel Corp | ZERBE ROBERT L MD
(Director) |
S | Common Stock | D | 300 | $38.00 - $38.06 | $11,406 |
| 2023-11-15 | Vericel Corp | Flynn Sean C.
(SVP, General Counsel) |
G | Common Stock | D | 1042 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |